CD274 and gastric cancer: Although, PDL1 IHC expression is a routinely used biomarker for predicting ICI response for multiple other malignancies, such as lung or gastric cancer, this has not been the case for CRC, as demonstrated for instance in sub-analysis of the CheckMate-9 × 8 trial [38].